Published in Cancer Res on August 01, 1983
Energy and protein metabolism in sarcoma patients. Ann Surg (1988) 0.78
Energetics of nutrition and polyamine-related tumor growth alterations in experimental cancer. Br J Cancer (1993) 0.78
Protein synthesis, myosin ATPase activity and myofibrillar protein composition in hearts from tumour-bearing rats and mice. Biochem J (1989) 0.76
Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients. Br J Surg (2009) 7.74
Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography. J Chromatogr (1982) 2.40
Toxicological studies on omeprazole. Scand J Gastroenterol Suppl (1985) 2.19
Integrated care for the elderly: the background and effects of the reform of Swedish care of the elderly. Int J Integr Care (2000) 2.16
ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr (2009) 2.05
Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg (1997) 1.71
Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60
Energy balance and body composition in cancer patients. Cancer Res (1978) 1.50
Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients. Eur J Cancer (2000) 1.49
Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer (1993) 1.46
Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res (1991) 1.44
Metabolic effects of structured triglycerides in humans. Nutr Clin Pract (1995) 1.43
Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer (1991) 1.41
Mouse extensor digitorum longus muscle preparation as a tool in nutrition research: a quantitative comparison to in vivo and cell culture experiments. Nutrition (1999) 1.41
[Further centralization of pediatric heart surgery is recommended]. Lakartidningen (1994) 1.40
Metabolism of methyl mercury (203Hg) compounds in man. Arch Environ Health (1969) 1.38
Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer (2001) 1.35
Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer (1976) 1.31
A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model. Cancer (1978) 1.29
Age-standardized incidence of ruptured aortic aneurysm in a defined Swedish population between 1952 and 1988: mortality rate and operative results. Br J Surg (1992) 1.28
The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg (1993) 1.26
Randomized controlled trial of prophylactic chest physiotherapy in major abdominal surgery. Br J Surg (1997) 1.24
Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J Immunol (1997) 1.23
Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper. Ther Drug Monit (1985) 1.21
Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J Immunol (1989) 1.18
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol (1987) 1.17
Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res (1982) 1.16
Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation. J Immunol (1995) 1.14
Effect on whole-body protein synthesis after institution of intravenous nutrition in cancer and non-cancer patients who lose weight. Eur J Cancer (1991) 1.14
The pancreas transplant program--Gothenburg, Sweden. Transplant Proc (1987) 1.13
Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection. J Immunol (1999) 1.10
Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol (1983) 1.09
Hearing impairment in patients with antibody production against Borrelia burgdorferi antigen. Lancet (1989) 1.09
Insulin resistance in patients with cancer. Cancer Res (1978) 1.08
Renal transplantation in the Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. Nephrol Dial Transplant (1991) 1.08
Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation. Metabolism (1984) 1.08
Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen (2000) 1.07
IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J Immunol (1996) 1.06
Outcome of renal transplantation in patients over the age of 60: a case-control study. Nephrol Dial Transplant (1995) 1.05
Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology (1997) 1.04
Relationship of food intake, body composition, and tumor growth to host metabolism in nongrowing mice with sarcoma. Cancer Res (1980) 1.03
Resting energy expenditure in malnourished patients with and without cancer. Gastroenterology (1984) 1.03
Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol (1986) 1.03
Bell's palsy and herpes simplex virus. Arch Otolaryngol (1981) 1.02
Insulin selectively attenuates breakdown of nonmyofibrillar proteins in peripheral tissues of normal men. Am J Physiol (1994) 1.02
Physical training in man. Skeletal muscle metabolism in relation to muscle morphology and running ability. Eur J Appl Physiol Occup Physiol (1977) 1.01
Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer (1982) 1.01
Postprandial stimulation of muscle protein synthesis is independent of changes in insulin. Am J Physiol (1997) 1.00
Clinical significance of preoperative nutritional status in 215 noncancer patients. Ann Surg (1984) 1.00
Bile acid concentrations in systemic and portal serum in presumably normal man and in cholestatic and cirrhotic conditions. Scand J Gastroenterol (1977) 0.99
Relationships between self-reported health related quality of life and measures of standardized exercise capacity and metabolic efficiency in a middle-aged and aged healthy population. Qual Life Res (2003) 0.99
Intermittent claudication--surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency. Ann Surg (1989) 0.99
Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck (1998) 0.98
Protein synthesis in liver tissue under the influence of a methylcholanthrene-induced sarcoma in mice. Cancer Res (1979) 0.98
Protein degradation in human skeletal muscle tissue: the effect of insulin, leucine, amino acids and ions. Clin Sci (Lond) (1981) 0.98
Glycerol dynamics in weight-losing cancer patients. Surgery (1985) 0.97
Acute traumatic tympanic membrane perforations. Cover or observe? Arch Otolaryngol Head Neck Surg (1987) 0.96
Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity. J Immunol (1999) 0.96
Unicellular or multicellular origin of human T-lymphocyte colonies in soft agar? Scand J Immunol (1981) 0.96
Identification of tissue sites for increased albumin degradation in sarcoma-bearing mice. J Surg Res (1991) 0.96
Flux of amino acids across the leg in weight-losing cancer patients. Cancer Res (1984) 0.95
Enterochromaffin-like cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion (1990) 0.95
Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol (2006) 0.94
Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cancer Res (2000) 0.94
Partial 6q deletion in a human salivary gland adenocarcinoma. Cancer Genet Cytogenet (1989) 0.94
Effect of systemic hyperinsulinemia on amino acid flux across human legs in postabsorptive state. Am J Physiol (1991) 0.93
Transport kinetics of amino acids across the resting human leg. J Clin Invest (1987) 0.93
A clinical comparison of hydrocortisone butyrate with oxytetracycline/hydrocortisone acetate-polymyxin B in the local treatment of acute external otitis. Eur Arch Otorhinolaryngol (1990) 0.93
Lethal complications following administration of oxytetracycline in the horse. Nord Vet Med (1971) 0.93
Metabolic response of whole body and peripheral tissues to enteral nutrition in weight-losing cancer and noncancer patients. Gastroenterology (1983) 0.93
Lysosomal enzyme activity in muscle tissue from patients with malignant tumor. Cancer (1972) 0.91
Whole-body tyrosine flux in relation to energy expenditure in weight-losing cancer patients. Metabolism (1984) 0.91
Glucocorticoid hormone binding to human adipose tissue. Eur J Clin Invest (1985) 0.91
Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. Nephrol Dial Transplant (1993) 0.91